Neutrophil-lymphocyte ratio (NLR) as a prognostic and predictive biomarker in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with cabazitaxel (CBZ) vs abiraterone or enzalutamide in the CARD study

Autor:	de Wit, R. Wuelfing, C. Castellano Gauna, D. Kramer, G. and Eymard, J-C. Sternberg, C. N. Fizazi, K. Tombal, B. and Bamias, A. Carles, J. Iacovelli, R. Melichar, B. and Sverrisdottir, A. Theodore, C. Feyerabend, S. Helissey, C. and Poole, E. M. Ozatilgan, A. Geffriaud-Ricouard, C. de Bono, J.
Jazyk:	angličtina
Rok vydání:	2020
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=od______2127::9003d04abb5cee92301d0fdf28148b27 https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3192214 Zobrazit plný text záznamu